User:Ryl3rs0n/Rabies vaccine

Source: Wikipedia, the free encyclopedia.

Article Draft: Contributions - Rabies vaccine

The rabies vaccine is a vaccine used to prevent rabies.[1] There are several rabies vaccines available that are both safe and effective.[1] Vaccinations must be administered prior to rabies virus exposure or within the latent period after exposure to prevent the disease.[2] They can be used to prevent rabies before, and, for a period of time, after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.[1] Transmission of rabies virus to humans typically occurs through a bite or scratch from an infectious animal, but exposure can occur through indirect contact with the saliva from an infectious individual.[2]

Doses are usually given by injection into the skin or muscle.[1] After exposure, the vaccination is typically used along with rabies immunoglobulin.[1] It is recommended that those who are at high risk of exposure be vaccinated before potential exposure.[1] Rabies vaccines are effective in humans and other animals, and vaccinating dogs is very effective in preventing the spread of rabies to humans.[1] A long-lasting immunity to the virus develops after a full course of treatment.[1]Rabies vaccines may be used safely by all age groups.[1] About 35 to 45 percent of people develop a brief period of redness and pain at the injection site, and 5 to 15 percent of people may experience fever, headaches, or nausea.[1] After exposure to rabies, there is no contraindication to its use, because the untreated virus is virtually 100% fatal.[1][3]

The first rabies vaccine was introduced in 1885 and was followed by an improved version in 1908.[4] Millions of people globally are vaccinated against the virus.[1] It is on the World Health Organization's List of Essential Medicines.[5][6]

Wild animals

Wildlife species, primarily bats, raccoons, skunks, and foxes, act as reservoir species for different variants of the rabies virus in distinct geographic regions of the United States.[7][8] This results in the general occurrence of rabies as well as outbreaks in animal populations.[7] Approximately 90% of all reported rabies cases in the US are from wildlife.[7]

Oral rabies vaccine

Oral rabies vaccines are distributed across the landscape, targeting reservoir species, in an effort in pellet form are intended to be given to wild animals to produce a herd immunity effect.[9] The idea of wildlife vaccination was conceived during the 1960s, and modified-live rabies viruses were used for the experimental oral vaccination of carnivores by the 1970s.[10] The Development of an oral immunization for wildlife began in the United States development of safe and effective rabies virus vaccines with laboratory trials using the live, attenuated Evelyn-Rokitnicki-Abselseth (ERA) vaccine, derived from the Street Alabama Dufferin (SAD) strain.[11] The first ORV field trial using the live attenuated vaccine to immunize foxes applied in attractive baits resulted in the first field trials and occured in Switzerland in during 1978 to immunize red foxes.[12][13]

There are currently three different types of oral wildlife rabies vaccine in use:

  • Modified live virus: Attenuated vaccine strains of rabies virus such as SAG2 and SAD B19. [14][15].
  • Recombinant vaccinia virus expressing rabies glycoprotein (V-RG): This is a strain of the vaccinia virus (originally a smallpox vaccine) that has been engineered to encode the gene for the rabies glycoprotein. It is mostly used in the USA (raccoons, foxes, and coyotes) and in western Europe (red foxes)[16]
    • The V-RG oral vaccine does not contain the whole rabies virus and has been proven safe in over 60 animal species including cats and dogs.[17][11] The idea of wildlife vaccination was conceived during the 1960s, and modified-live rabies viruses were used for the experimental oral vaccination of carnivores by the 1970s.
  • ONRAB: an experimental live recombinant adenovirus vaccine [18][19]

Oral rabies vaccination (ORV) programs have been used in many countries in an effort to control the spread of rabies and limit the risk of human contact with the rabies virus.[7] ORV programs were initiated in Europe in the 1980s, Canada in 1985, and in the United States in 1990.[20] ORV is a preventive measure to eliminate eradicate rabies in wild animal vectors of disease, mainly foxes, raccoons, raccoon dogs, coyotes and jackals, but also can be used for dogs in developing countries.[21] ORV programs typically use edible attractive baits to deliver the vaccine to targeted animals.[9] In the United States, RABORAL V-RG (Boehringer Ingelheim, Duluth, GA, USA) has been the only licensed ORV for rabies virus management since 1997.[11] However, ONRAB "Ultralite" (Artemis Technologies Inc., Guelph, Ontario, Canada) baits have been distributed by the United States Department of Agriculture (USDA) in select areas of the eastern United States under an experimental permit to target raccoons since 2011.[22]

RABORAL V-RG baits consist of a small packet containing the oral vaccine which is then either coated in a fishmeal paste or encased in a fishmeal-polymer block.[7] ONRAB "Ultralite" baits consist of a blister pack with a coating matrix of vanilla flavor, green food coloring, vegetable oil and hydrogenated vegetable fat.[19] When an animal bites into the bait, the packets burst and the vaccine is administered.[20] Current research suggests that if adequate amounts of the vaccine is ingested, immunity to the virus should last for upwards of one year.[17] By immunizing wild or stray animals, ORV programs work to create a buffer zone between the rabies virus and potential contact with humans, pets, or livestock.[20] Landscape features such as large bodies of water and mountains are often used to enhance the effectiveness of the buffer.[23] The effectiveness of ORV campaigns in specific areas is determined through trap-and-release methods.[24] Titer tests are performed on the blood drawn from the sample animals in order to measure rabies antibody levels in the blood.[24] Baits are usually distributed by aircraft to more efficiently cover large, rural regions. In order to place baits more precisely and to minimize human and pet contact with baits, however, they are distributed by hand in suburban or urban regions.[20] The standard bait distribution density is 75 baits/km2 in rural areas and 150 baits/km2 in urban and developed areas.[11]

Implementation of ORV programs in the United States has led seen to the elimination of the coyote rabies virus variant in 2003 and gray fox variant during 2013.[25][26] Furthermore, ORV has been successful in preventing the westward spread of raccoon rabies variant and even eradicating rabies in red foxes in Switzerland.[27][28][9]

The oral vaccine does not contain the whole rabies virus and has been proven safe in over 60 animal species including cats and dogs.[17][11] The idea of wildlife vaccination was conceived during the 1960s, and modified-live rabies viruses were used for the experimental oral vaccination of carnivores by the 1970s. The potential for human contact with baits is a present concern for ORV programs, but the inactivated rabies vaccine cannot cause rabies, and the recombinant poxvirus vaccine is based on an attenuated poxvirus which is unlikely to cause serious disease in humans anyway. In the USA between 1990 and 2000, over 22 million doses of vaccinia-rabies were distributed, but there were only 160 incidents of people touching a vaccine bait, and only one resulted in a serious infection. The person in this case had been bitten by her dog while removing a bait from its mouth.[29]

References

  1. ^ a b c d e f g h i j k l World Health Organization (2018). "Rabies vaccines: WHO position paper – April 2018" (PDF). Weekly Epidemiological Record. 93 (16): 201–19. hdl:10665/272372. Archived (PDF) from the original on 7 October 2022. Retrieved 28 August 2022.
  2. ^ a b Rupprecht, Charles E; Hanlon, Cathleen A; Hemachudha, Thiravat (2002). "Rabies re-examined". The Lancet Infectious Diseases. 2 (6): 327–343. doi:10.1016/S1473-3099(02)00287-6.
  3. ^ News, GISELLE OMBAY, GMA Integrated (2023-10-10). "Rabies 99.9% fatal, but highly preventable —PCP". GMA News Online. Retrieved 2023-10-14. {{cite web}}: |last= has generic name (help)CS1 maint: multiple names: authors list (link)
  4. ^ Nunnally B (2014). Vaccine Analysis: Strategies, Principles, and Control. Springer. p. 63. ISBN 9783662450246. Archived from the original on 5 March 2016.
  5. ^ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
  6. ^ World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
  7. ^ a b c d e "Oral Rabies Vaccination". Animal and Plant Health Inspection Service (APHIS). Archived from the original on 8 July 2020. Retrieved 12 November 2019.
  8. ^ Gilbert A., T. (2018-08-01). "Rabies virus vectors and reservoir species: -EN- Rabies virus vectors and reservoir species -FR- Les vecteurs du virus de la rage et les espèces réservoirs -ES- Especies vector y reservorio del virus de la rabia". Revue Scientifique et Technique de l'OIE. 37 (2): 371–384. doi:10.20506/rst.37.2.2808. ISSN 0253-1933.
  9. ^ a b c Chipman, Richard B.; Gilbert, Amy T.; Slate, Dennis (2023), Rupprecht, Charles E. (ed.), "Wildlife Rabies Management in the New World: Prevention, Control and Elimination in Mesocarnivores", History of Rabies in the Americas: From the Pre-Columbian to the Present, Volume I, Cham: Springer International Publishing, pp. 143–198, doi:10.1007/978-3-031-25052-1_7, ISBN 978-3-031-25051-4, retrieved 2023-10-25
  10. ^ Baer, G. M. (1994). "Rabies--an historical perspective". Infectious Agents and Disease. 3 (4): 168–180. ISSN 1056-2044. PMID 7827785.
  11. ^ a b c d e Maki, Joanne; Guiot, Anne-Laure; Aubert, Michel; Brochier, Bernard; Cliquet, Florence; Hanlon, Cathleen A.; King, Roni; Oertli, Ernest H.; Rupprecht, Charles E.; Schumacher, Caroline; Slate, Dennis; Yakobson, Boris; Wohlers, Anne; Lankau, Emily W. (2017). "Oral vaccination of wildlife using a vaccinia–rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG®): a global review". Veterinary Research. 48 (1). doi:10.1186/s13567-017-0459-9. ISSN 1297-9716. PMC 5610451. PMID 28938920.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
  12. ^ Rupprecht CE, Hanlon CA, Slate D (2004). "Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control". Developments in Biologicals. 119: 173–184. PMID 15742629.
  13. ^ Winkler, William G.; Bögel, Konrad (1992). "Control of Rabies in Wildlife". Scientific American. 266 (6): 86–91. doi:10.1038/scientificamerican0692-86. ISSN 0036-8733.
  14. ^ "Field application of oral rabies vaccines for dogs" (PDF). Report of a WHO Consultation organized in collaboration with the Office International des Epizooties (OIE). Geneva, Switzerland: World Health Organization. July 1998. Archived from the original (PDF) on 14 October 2006.
  15. ^ Wandeler, A. I.; Capt, S.; Kappeler, A.; Hauser, R. (1988-11-01). "Oral Immunization of Wildlife Against Rabies: Concept and First Field Experiments". Clinical Infectious Diseases. 10 (Supplement_4): S649–S653. doi:10.1093/clinids/10.Supplement_4.S649. ISSN 1537-6591.
  16. ^ Maki J, Guiot AL, Aubert M, Brochier B, Cliquet F, Hanlon CA, et al. (September 2017). "Oral vaccination of wildlife using a vaccinia-rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG®): a global review". Veterinary Research. 48 (1). Springer Science and Business Media LLC: 57. doi:10.1186/s13567-017-0459-9. PMC 5610451. PMID 28938920.
  17. ^ a b c "Frequently Asked Questions". Animal and Plant Health Inspection Service (APHIS). 12 November 2019. Archived from the original on 17 August 2020. Retrieved 19 November 2019.
  18. ^ Tordo N, Foumier A, Jallet C, Szelechowski M, Klonjkowski B, Eloit M (2008). "Canine adenovirus based rabies vaccines". Developments in Biologicals. 131: 467–476. PMID 18634509. Archived from the original on 29 January 2023. Retrieved 2023-01-29.
  19. ^ a b Fehlner-Gardiner, Christine; Rudd, Robert; Donovan, Dennis; Slate, Dennis; Kempf, Libby; Badcock, Jacqueline (2012). "COMPARING ONRAB ® AND RABORAL V-RG ® ORAL RABIES VACCINE FIELD PERFORMANCE IN RACCOONS AND STRIPED SKUNKS, NEW BRUNSWICK, CANADA, AND MAINE, USA". Journal of Wildlife Diseases. 48 (1): 157–167. doi:10.7589/0090-3558-48.1.157. ISSN 0090-3558.
  20. ^ a b c d "Oral Rabies Vaccine Information". Animal and Plant Health Inspection Service (APHIS). 12 November 2019. Archived from the original on 14 November 2019. Retrieved 18 November 2019.
  21. ^ "Oral rabies vaccination". Archived from the original on 7 January 2014. Retrieved 21 February 2014.
  22. ^ Gilbert, Amy; Johnson, Shylo; Walker, Nikki; Wickham, Chad; Beath, Alex; VerCauteren, Kurt (2018). "Efficacy of Ontario Rabies Vaccine Baits (ONRAB) against rabies infection in raccoons". Vaccine. 36 (32): 4919–4926. doi:10.1016/j.vaccine.2018.06.052.
  23. ^ Algeo, Timothy; Slate, Dennis; Caron, Rosemary; Atwood, Todd; Recuenco, Sergio; Ducey, Mark; Chipman, Richard; Palace, Michael (2017-08-28). "Modeling Raccoon (Procyon lotor) Habitat Connectivity to Identify Potential Corridors for Rabies Spread". Tropical Medicine and Infectious Disease. 2 (3): 44. doi:10.3390/tropicalmed2030044. ISSN 2414-6366. PMC 6082097. PMID 30270901.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
  24. ^ a b "Oral Rabies Vaccination Program in the East" (PDF). Animal and Plant Health Inspection Service (APHIS). January 2011. Archived from the original (PDF) on 11 February 2017. Retrieved 19 November 2019.
  25. ^ Sidwa, Thomas J.; Wilson, Pamela J.; Moore, Guy M.; Oertli, Ernest H.; Hicks, Bradley N.; Rohde, Rodney E.; Johnston, David H. (2005-09-01). "Evaluation of oral rabies vaccination programs for control of rabies epizootics in coyotes and gray foxes: 1995–2003". Journal of the American Veterinary Medical Association. 227 (5): 785–792. doi:10.2460/javma.2005.227.785. ISSN 0003-1488.
  26. ^ Blanton, Jesse D.; Hanlon, Cathleen A.; Rupprecht, Charles E. (2007-08-15). "Rabies surveillance in the United States during 2006". Journal of the American Veterinary Medical Association. 231 (4): 540–556. doi:10.2460/javma.231.4.540. ISSN 0003-1488.
  27. ^ "Oral Rabies Vaccine Project – Environmental Epidemiology". www.vdh.virginia.gov. Archived from the original on 18 August 2017. Retrieved 23 July 2017.
  28. ^ "Switzerland's Kind of Gross, Incredibly Effective Anti-Rabies Weapon | Now I Know". nowiknow.com. Archived from the original on 12 February 2016. Retrieved 23 July 2017.
  29. ^ Rupprecht CE, Blass L, Smith K, Orciari LA, Niezgoda M, Whitfield SG, et al. (August 2001). "Human infection due to recombinant vaccinia-rabies glycoprotein virus". The New England Journal of Medicine. 345 (8): 582–586. doi:10.1056/NEJMoa010560. PMID 11529212.